NEW YORK (GenomeWeb) – The National Cancer Institute will provide up to $4.5 million next year to fund research teams performing omics studies to characterize tumor lesions discovered through screening, with the aim of better predicting which lesions are progressive and require interventions and which are indolent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.